Fortrea Holdings Inc. (NASDAQ:FTRE) Q2 2024 Results Conference Call August 12, 2024 9:00 AM ET Company Participants Hima Inguva - Head of Investor Relations, Corporate Development Tom Pike - Chairman, Chief Executive Officer Jill McConnell - Chief Financial Officer Conference Call Participants David Windley - Jefferies Patrick Donnelly - Citi Luke Sergott - Barclays Elizabeth Anderson - Evercore Justin Bowers - DB Max Smock - William Blair Charles Rhyee - TD Cowen Eric Coldwell - Baird Michael Ryskin - Bank ...

Fortrea Holdings Inc. (FTRE) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.07. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -142.86%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced a loss of $0.04, delivering a surprise of -300%. Over the last four quarters, the company has surpas ...

Exhibit 99.1 ✈ Fortrea Fortrea Reports Second Quarter 2024 Results For the three months ended June 30, 2024, from continuing operations: • Revenues of $662.4 million • GAAP net loss of $(99.3) million • Adjusted EBITDA of $55.2 million • GAAP and adjusted loss per share of $(1.11) and $(0.03), respectively • Book-to-bill ratio of 0.96x, resulting in 1.16x book-to-bill for the trailing 12 months • Completed divestiture of assets relating to the Endpoint Clinical and Patient Access businesses • Debt paydown o ...

For the three months ended June 30, 2024, from continuing operations: Revenues of $662.4 million GAAP net loss of $(99.3) million Adjusted EBITDA of $55.2 million GAAP and adjusted diluted loss per share of $(1.11) and $(0.03), respectively Book-to-bill ratio of 0.96x, resulting in 1.16x book-to-bill for the trailing 12 months Completed divestiture of assets relating to the Endpoint Clinical and Patient Access businesses Debt paydown of $504 million in the quarter using initial divestiture and securitizatio ...

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link. About Fortrea Fortrea Contacts: A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations w ...

DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that it will release its second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Fortrea will host a conference call at 9:00 am ET that day to review its financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea Investor Relatio ...

Parks brings three decades of experience to the role. Starting his career in public accounting at Ernst & Young LLP, he served clients in global and regulated industries, including defense and construction. He was senior vice president and corporate controller at Quintiles, now IQVIA, and CAO at Syneos, a leading biopharmaceutical solutions organization. Most recently, Parks served as CAO at SailPoint Technologies Holdings, a leader in identity security software. He is a certified public accountant and earn ...

"We are pleased to welcome Bobby to the Fortrea team, bringing his broad and deep experience from CROs and other fast-paced environments," said Fortrea Chief Financial Officer Jill McConnell. "Bobby has a track record of managing Sarbanes-Oxley Act requirements and internal controls, including for CROs, in a public-company setting. He is a strategic thinker who understands our customers and our business priorities. I look forward to Bobby making a fast start as CAO and a significant contribution to Fortrea' ...

北卡罗来纳州，达勒姆市, June 28, 2024 (GLOBE NEWSWIRE) -- 全球领先的合同研究组织 (CRO) Fortrea (Nasdaq: FTRE) 今天宣布推出人工智能 (AI) 创新工作室，标志着该公司在重塑当今及未来临床试验执行方面的战略投资。 该工作室将开发和部署 AI 和机器学习 (ML) 技术，通过装备和授权人员专注于临床试验中关键的人为因素，提升临床研究过程中的速度、敏捷性、质量并增强患者安全性。 “全世界的患者都在等待改变生活的新颖疗法。有了 AI，我们现在有能力也有义务更快地为他们提供解决方案，”Fortrea 首席信息官 Alejandro Martinez Galindo 说道。 “Fortrea 的 AI 创新工作室将增强技术能力，使 AI 赋能系统能够执行先进流程，如试验模拟、预测分析和模式识别，以及重复性、管理性、‘机器友好型任务’。如此一来，人们就可以解放出来，为未来的临床试验贡献人类的创造力和联系，并专注于最重要的事情：患者。” Fortrea 的 AI 创新工作室旨在： 在 Fortrea 内部以及与我们的客户合作，为定制研究中心和申办者创新战略提供 ...

The studio will develop and deploy AI and machine learning (ML) technologies to drive speed, agility, quality and enhanced patient safety in the clinical research process by equipping and empowering people to focus on the critical human element of clinical trials. "Fortrea's AI Innovation Studio will enable enhanced technological capabilities that will allow AI-enabled systems to perform cutting-edge processes—such as trial simulations, predictive analytics and pattern recognition—as well as repetitive, adm ...